$IBO a stock bloating with a massive share count on the TSX-V A billion stock trading for mere pennies in the market, I bought this highly exclusive stock $IBO a week ago and always had a satisfying experience ever since.
Microcap
$IBO announced a vital addition of clinical trials director
Julie Dumouchel has been named Director of Clinical Trials at UI, which is a significant strategic move. Julie Dumouchel has 25 years of experience in the pharmaceutical sector, where she has worked in a variety of clinical research jobs and has a thorough grasp of the drug development process.
$IBO propagating effortlessly, investors under the clutch
$IBO has exceptional potential when it comes to volatility, and the share prices have been hiking lately, last closing of the stock trading at $0.0400 on TSX-V with a noted spike
$IBO the globally renowned stock investment trading at max speed
$IBO don’t ever shy out from attaining peaks in the market and delivering unimaginable profit to the shareholders, the shares are trading yesterday with a massive spike of 11.11%, at $0.05 with substantial incline
$DIA oozing with oodles of profit in the market, don't miss the
$DIA, an exploration stage company, engages in the exploration and acquisition of mineral properties in Canada, and is currently trading at $0.1750, with a great jump in the market. As per the charts the stock is expected to follow a bullish pattern.
$IBO trading at its all time high, an offer you cannot refuse bu
$IBO don’t ever shy out from attaining peaks in the market and delivering unimaginable profit to the shareholders, the shares are trading with a massive spike at $0.045 with substantial incline
$IBO a stock lock and loaded with profit and momentum on the TSX
$IBO is moving ahead with courage and compassion on the TSX-V, the stock is rising in leaps and bounds in the market, shares are effectively trading at $0.045 with a rise in value
$IBO ahead with a beguiling stock presentation in the market
$IBO has exceptional potential when it comes to volatility, and the share prices have been hiking lately,
$IBO with an enlivening incline on the TSX-V, Best bargain in th
$IBO is currently trading with enormous pace and is trying to disrupt its target price before time with every piece of effort it can foster, the shares are trading at $0.045 with volume of 24k
$IBO with an exhilarating ascent on the TSX-V, Best bargain in t
$IBO is currently trading with enormous pace and is trying to disrupt its target price before time with every piece of effort it can foster, the shares are trading at $0.05
$HEM declared the addition of an entirely closely-held subsidiar
Hemostemix recently declared the incorporation of PreCerv inc . (A totally closely-held subsidiary of Hemostemix). Hemostemix can grant PreCerv a world field of use licence for NCP-01 and its autologous somatic cell technology to treat central and peripheral systema nervosum diseases.
$HEM grants worldwide field license to PreCerv Inc.
Hemostemix recently granted the global field license of use of NCP-01 and its autologous stem cell therapies to PreCerv Inc. its wholly owned subsidiary to aid patients with peripheral and central nervous system conditions
$IBO Addiction Treatment Technology
Universal Ibogaine Inc. is a life science company with a mission to transform addiction treatment through the use of medicalized ibogaine and a global licensing model through a planned Canadian Clinical trial.
Universal Ibogaine Market Summary
Universal Ibogaine Inc. holds a significant position over the TSX-V market with its greater difference between the lower and higher ranges of trading, which is $0.0400-$0.2500 in the last 52 weeks.
$IBO stock analysis and evaluation
$IBO stock ticker to Universal Ibogaine a company that provides ibogaine addiction treatment to patients tormented from opioid addiction in Canada is currently trading rapidly at $0.0500 with no loss as such
Reward enjoyed by UI on listing on the Frankfurt stock exchange
The Frankfurt Stock Exchange (FSE) is Germany's largest stock exchange and the leading European destination for Canadian venture capital firms seeking exposure and liquidity in the European market. The FSE enables advanced electronic trading, settlement, and information technologies, allowing it to handle the increasing demands of cross-border trading.
Hemostemix Inc. interest payment on convertible debenture
Hemostemix Inc. announced that it will pay interest of $84,804.40 by issuing 446,339 Common Shares, using the March 2, 2022 closing price of $0.19 per share, to the convertible debenture holder in satisfaction of interest due on the outstanding principal amount of $2,500,000 for the period from inception, June 11, 2021, to December 31, 2021.
Every TA Persons Favorite Chart $FearAll altcoins are affected by Bitcoins gravity but we've seen many exceptions to this rule especially during crypto/stock market rallies. $Fear is a Gaming/metaverse company specializing in making successful horror games and now has brought their already popular games to the blockchain. This coin is listed on Kucoin and I have been dollar-cost averaging in as I believe it is massively undervalued. You can check out their website if you care to learn more its Fear.io
$IBO market cap improved $9.5 Million mark in the market$IBO has surpassed its market cap valuation again twice in a row and is persistently moving ahead the current cap valuation according to market context is $9.53 Million
$IBO is currently trading with enormous pace and is trying to disrupt its target price before time with every piece of effort it can foster, the shares are trading at $0.05
$IBO contract with blue digital media dictates further benefits
Blue Digital will be paid USD 27,000 for a three-month commitment beginning June 13, 2022. Additionally, Blue Digital will get 450,000 company's stock options to purchase common shares of the Company, with an exercise price of $0.10 per share, a three-year term, and one-third vesting at the conclusion of each month of service.
Universal Ibogaine Inc. stock analysis and evaluation
Universal Ibogaine Inc. is Canadian-registered company listed on TSX-V with ticker symbol $IBO marked an opening today at $0.05
Market Cap Insights of $IBO$IBO continues to develop a sound and sturdy market cap over the period since the trading has begun on the TSX-V platform. The company currently holds a reasonable market cap of 9.5 million+.
$IBO ascending forward on TSX-V$IBO is trading swiftly in the market and observed a plenty of investor activities, the shares are trading live on TSX-V at $0.055
